{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T11:24:39Z","timestamp":1785842679608,"version":"3.56.0"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,10,22]],"date-time":"2019-10-22T00:00:00Z","timestamp":1571702400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2019,10,22]],"date-time":"2019-10-22T00:00:00Z","timestamp":1571702400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Fund of Research and Development Program of Beijing Shunyi Health Planning Commissio","award":["Wsjskyfzzx-z-04"],"award-info":[{"award-number":["Wsjskyfzzx-z-04"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"published-print":{"date-parts":[[2019,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n              <jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>On 7th June, 2018, a primary school in Beijing, China notified Shunyi CDC of an outbreak of acute respiratory disease characterized by fever and cough among students and resulting in nine hospitalization cases during the preceding 2\u2009weeks. We started an investigation to identify the etiologic agent, find additional cases, develop and implement control measures.<\/jats:p>\n              <\/jats:sec>\n              <jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>We defined probable cases as students, teachers and other staffs in the school developed fever (T\u2009\u2265\u200937.5\u2009\u00b0C) with cough or sore throat; or a diagnosis of pneumonia during May 1\u2013June 31, 2018. Confirmed cases were probable cases with Mycoplasma pneumoniae detected in oropharyngeal\u00a0(OP) swabs by quantitative real-time polymerase chain reaction (qPCR). We searched case by reviewing school absenteeism records and interviewing students, teachers and staff in this school. Oropharyngeal swabs were collected from symptomatic students. Two qPCR) assay, a duplex qPCR assay, and sequencing were performed to determine the pathogen, genotype and macrolide resistance at the gene level, respectively.<\/jats:p>\n              <\/jats:sec>\n              <jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>From May 1st to June 31st, 2018, we identified 55 cases (36 probable and 19 confirmed), of whom 25 (45%) were hospitalized for complications. All cases were students, none of the teachers and other staffs in the school were with similar symptoms. The attack rate (AR) was 3.9% (55\/1398) for all students. The cases were mainly male (58%), with an age range of 7\u20138\u2009years (median: 7\u2009years). 72% (18\/25) of inpatients had radiograph findings consistent with pneumonia, and some cases were hospitalized for up to 4\u2009weeks. Pathogen detection results indicated that Mycoplasma pneumonia (M. pneumoniae) P1 type 1 was the causative agent in this outbreak, and the strain harbored one point mutation of A to G at position 2063.<\/jats:p>\n              <\/jats:sec>\n              <jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>The infections by macrolide-resistant M. pneumoniae are not always mild and pneumonia was common and M. pneumoniae could causes serious complications which require long-term hospitalization. In the future infectious disease prevention and control practice, M. pneumoniae should be paid more attention. It is necessary to establish and improve the pathogen and drug resistance surveillance system in order to prevent and control such mutated strains of M. pneumoniae from causing future outbreaks or epidemics in China.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12879-019-4473-6","type":"journal-article","created":{"date-parts":[[2019,10,23]],"date-time":"2019-10-23T04:29:57Z","timestamp":1571804997000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":24,"title":["Outbreak of macrolide-resistant mycoplasma pneumoniae in a primary school in Beijing, China in 2018"],"prefix":"10.1186","volume":"19","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1155-479X","authenticated-orcid":false,"given":"Wen-Zeng","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Song-Jian","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Quan-Yi","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yin-Dong","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong-Bo","family":"Jing","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guang-Yi","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dan","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,10,22]]},"reference":[{"issue":"6","key":"4473_CR1","doi-asserted-by":"publisher","first-page":"956","DOI":"10.1111\/j.1574-6976.2008.00129.x","volume":"32","author":"TP Atkinson","year":"2008","unstructured":"Atkinson TP, Balish MF, Waites KB. Epidemiology, clinical manifestations, pathogenesis and laboratory detection of mycoplasma pneumonia infections. FEMS Microbiol Rev. 2008;32(6):956\u201373.","journal-title":"FEMS Microbiol Rev"},{"key":"4473_CR2","doi-asserted-by":"publisher","first-page":"506","DOI":"10.1093\/jac\/dks457","volume":"68","author":"N Principi","year":"2013","unstructured":"Principi N, Esposito S. Macrolide-resistant Mycoplasma pneumoniae: its role in respiratory infection. J Antimicrob Chemother. 2013;68:506\u201311. \n                    https:\/\/doi.org\/10.1093\/jac\/dks457\n                    \n                  .","journal-title":"J Antimicrob Chemother"},{"issue":"7","key":"4473_CR3","doi-asserted-by":"publisher","first-page":"535","DOI":"10.14740\/jocmr3421w","volume":"10","author":"B Bajantri","year":"2018","unstructured":"Bajantri B, Venkatram S, Diaz-Fuentes G. Mycoplasma pneumoniae: a potentially severe infection. J Clin Med Res. 2018;10(7):535\u201344. \n                    https:\/\/doi.org\/10.14740\/jocmr3421w\n                    \n                  .","journal-title":"J Clin Med Res"},{"issue":"2","key":"4473_CR4","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1086\/653535","volume":"51","author":"B Cao","year":"2010","unstructured":"Cao B, Zhao CJ, Yin YD, Zhao F, Song SF, Bai L, Zhang JZ, Liu YM, Zhang YY, Wang H, et al. High prevalence of macrolide resistance in Mycoplasma pneumoniae isolates from adult and adolescent patients with respiratory tract infection in China. Clin Infect Dis. 2010;51(2):189\u201394.","journal-title":"Clin Infect Dis"},{"key":"4473_CR5","doi-asserted-by":"publisher","first-page":"324","DOI":"10.2174\/15733963113099990009","volume":"9","author":"JM Winchell","year":"2013","unstructured":"Winchell JM. Mycoplasma pneumoniae\u2014a National Public Health perspective. Curr Pediatr Rev. 2013;9:324\u201333. \n                    https:\/\/doi.org\/10.2174\/15733963113099990009\n                    \n                  .","journal-title":"Curr Pediatr Rev"},{"issue":"5","key":"4473_CR6","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1016\/j.jinf.2005.07.005","volume":"51","author":"S Tsiodras","year":"2005","unstructured":"Tsiodras S, Kelesidis I, Kelesidis T, Stamboulis E, Giamarellou H. Central nervous system manifestations of Mycoplasma pneumoniae infections. J Inf Secur. 2005;51(5):343\u201354. \n                    https:\/\/doi.org\/10.1016\/j.jinf.2005.07.005\n                    \n                  .","journal-title":"J Inf Secur"},{"issue":"2","key":"4473_CR7","doi-asserted-by":"publisher","first-page":"e386","DOI":"10.1542\/peds.2015-0278","volume":"136","author":"D Olson","year":"2015","unstructured":"Olson D, Watkins LK, Demirjian A, Lin X, Robinson CC, Pretty K, Benitez AJ, et al. Outbreak of Mycoplasma pneumoniae-associated Stevens-Johnson syndrome. Pediatrics. 2015;136(2):e386\u201394. \n                    https:\/\/doi.org\/10.1542\/peds.2015-0278\n                    \n                  .","journal-title":"Pediatrics"},{"key":"4473_CR8","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1093\/jac\/dkp160","volume":"64","author":"O Peuchant","year":"2009","unstructured":"Peuchant O, Menard A, Renaudin H, Morozumi M, Ubukata K, Bebear CM, Pereyre S. Increased macrolide resistance of mycoplasma pneumonia in France directly detected in clinical specimens by qPCR and melting curve analysis. J Antimicrob Chemother. 2009;64:52\u20138.","journal-title":"J Antimicrob Chemother"},{"key":"4473_CR9","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1111\/j.1469-0691.2009.02968.x","volume":"16","author":"R Dumke","year":"2010","unstructured":"Dumke R, von Baum H, Luck PC, Jacobs E. Occurrence of macrolide-resistant Mycoplasma pneumoniae strains in Germany. Clin Microbiol Infect. 2010;16:613\u20136.","journal-title":"Clin Microbiol Infect"},{"issue":"1","key":"4473_CR10","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1128\/JCM.02597-14","volume":"53","author":"MH Diaz","year":"2015","unstructured":"Diaz MH, Benitez AJ, Winchell JM. Investigations of Mycoplasma pneumoniae infections in the United States: trends in molecular typing and macrolide resistance from 2006 to 2013. J Clin Microbiol. 2015;53(1):124\u201330. \n                    https:\/\/doi.org\/10.1128\/JCM.02597-14\n                    \n                  .","journal-title":"J Clin Microbiol"},{"issue":"5","key":"4473_CR11","doi-asserted-by":"publisher","first-page":"2160","DOI":"10.1128\/AAC.01684-08","volume":"53","author":"Y Liu","year":"2009","unstructured":"Liu Y, Ye X, Zhang H, Xu X, Li W, Zhu D, et al. Antimicrobial suscepetibility of Mycoplasma pneumoniae isolates and molecular analysis of macrolide-resistant from Shanghai, China. Antimicrob Agents Chenother. 2009;53(5):2160\u20132. \n                    https:\/\/doi.org\/10.1128\/AAC.01684-08\n                    \n                  .","journal-title":"Antimicrob Agents Chenother"},{"key":"4473_CR12","doi-asserted-by":"publisher","first-page":"1521","DOI":"10.1128\/AAC.02060-12","volume":"57","author":"F Zhao","year":"2013","unstructured":"Zhao F, Liu G, Wu J, Cao B, Tao X, He L, et al. Surveillance of macrolide-resistant mycoplasma pneumonia in Beijing, China, from 2008 to 2012. Antimicrob Agents Chemother. 2013;57:1521\u20133. \n                    https:\/\/doi.org\/10.1128\/AAC.02060-12\n                    \n                  .","journal-title":"Antimicrob Agents Chemother"},{"key":"4473_CR13","doi-asserted-by":"publisher","first-page":"3560","DOI":"10.1128\/JCM.01983-15","volume":"53","author":"PL Ho","year":"2015","unstructured":"Ho PL, Law PY, Chan BW, Wong CW, To KK, Chiu SS, et al. Emergence of macrolide-resistant Mycoplasma pneumoniae in Hong Kong is linked to increasing macrolide resistance in multilocus variable-number tandem-repeat analysis type 4-5-7-2. J Clin Microbiol. 2015;53:3560\u20134. \n                    https:\/\/doi.org\/10.1128\/JCM.01983-15\n                    \n                  .","journal-title":"J Clin Microbiol"},{"key":"4473_CR14","doi-asserted-by":"publisher","first-page":"1703","DOI":"10.3201\/eid2310.170106","volume":"23","author":"T Tanaka","year":"2017","unstructured":"Tanaka T, Oishi T, Miyata I, et al. Macrolide-resistant Mycoplasma pneumoniae infection, Japan, 2008-2015. Emerg Infect Dis. 2017;23:1703\u20136. \n                    https:\/\/doi.org\/10.3201\/eid2310.170106\n                    \n                  .","journal-title":"Emerg Infect Dis"},{"issue":"30","key":"4473_CR15","first-page":"603","volume":"62","author":"Centers for Disease Control and Prevention (CDC)","year":"2013","unstructured":"Centers for Disease Control and Prevention (CDC). Mycoplasma pneumoniae outbreak at a university - Georgia, 2012. MMWR Morb Mortal Wkly Rep. 2013;62(30):603\u20136.","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"4473_CR16","first-page":"296","volume":"64","author":"DL Hastings","year":"2015","unstructured":"Hastings DL, Harrington KJ, Kutty PK, Rayman RJ, Spindola D, Diaz MH, Thurman KA, Winchell JM, Safranek TJ. Centers for Disease Control and Prevention (CDC). Mycoplasma pneumoniae outbreak in a long-term care facility\u2013Nebraska, 2014. MMWR Morb Mortal Wkly Rep. 2015;64:296\u20139.","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"4473_CR17","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1097\/INF.0b013e31827aa7bd","volume":"32","author":"Y Suzuki","year":"2013","unstructured":"Suzuki Y, Itagaki T, Seto J, Kaneko A, Abiko C, Mizuta K, Matsuzaki Y. Community outbreak of macrolide-resistant Mycoplasma pneumoniae in Yamagata, Japan in 2009. Pediatr Infect Dis J. 2013;32:237\u201340. \n                    https:\/\/doi.org\/10.1097\/INF.0b013e31827aa7bd\n                    \n                  .","journal-title":"Pediatr Infect Dis J"},{"issue":"7","key":"4473_CR18","doi-asserted-by":"publisher","first-page":"3748","DOI":"10.1128\/AAC.00142-1256","volume":"56","author":"Y Wang","year":"2012","unstructured":"Wang Y, Qiu S, Yang G, Song L, Su W, Xu Y, et al. An outbreak of Mycoplasma pneumoniae caused by a macrolide-resistant isolate in a nursery school in China. Antimicrob Agents Chemother. 2012;56(7):3748\u201352. \n                    https:\/\/doi.org\/10.1128\/AAC.00142-1256\n                    \n                  .","journal-title":"Antimicrob Agents Chemother"},{"issue":"7","key":"4473_CR19","doi-asserted-by":"publisher","first-page":"4310","DOI":"10.1128\/AAC.00198-16","volume":"60","author":"Y Wang","year":"2016","unstructured":"Wang Y, Ye Q, Yang D, Ni Z, Chen Z. Study of two separate types of macrolide-resistant Mycoplasma pneumoniae outbreaks. Antimicrob Agents Chemother. 2016;60(7):4310\u20134. \n                    https:\/\/doi.org\/10.1128\/AAC.00198-16\n                    \n                  .","journal-title":"Antimicrob Agents Chemother"},{"issue":"7","key":"4473_CR20","doi-asserted-by":"publisher","first-page":"541","DOI":"10.3760\/cma.j.issn.0254-5101.2013.07.012","volume":"33","author":"AH Li","year":"2013","unstructured":"Li AH, Zhang TG, Shi WX, et al. A comparison of three methods for detecting respiratory viruse. Chin J Microbiol Immunol. 2013;33(7):541\u20134. \n                    https:\/\/doi.org\/10.3760\/cma.j.issn.0254-5101.2013.07.012\n                    \n                  .","journal-title":"Chin J Microbiol Immunol"},{"issue":"10","key":"4473_CR21","doi-asserted-by":"publisher","first-page":"e0141702","DOI":"10.1371\/journal.pone.0141702","volume":"10","author":"F Zhao","year":"2015","unstructured":"Zhao F, Liu L, Tao X, He L, Meng F, Zhang J. Culture-independent detection and genotyping of Mycoplasma pneumoniae in clinical specimens from Beijing, China. PLoS One. 2015;10(10):e0141702. \n                    https:\/\/doi.org\/10.1371\/journal.pone.0141702\n                    \n                  .","journal-title":"PLoS One"},{"key":"4473_CR22","doi-asserted-by":"publisher","first-page":"4624","DOI":"10.1128\/AAC.48.12.4624-4630","volume":"48","author":"M Matsuoka","year":"2004","unstructured":"Matsuoka M, Narita M, Okazaki N, Ohya H, Yamazaki T, Ouchi K, et al. Characterization and molecular analysis of macrolide-resistant Mycoplasma pneumoniae clinical isolates obtained in Japan. Antimicrob Agents Chemother. 2004;48:4624\u201330. \n                    https:\/\/doi.org\/10.1128\/AAC.48.12.4624-4630\n                    \n                  .","journal-title":"Antimicrob Agents Chemother"},{"issue":"9","key":"4473_CR23","doi-asserted-by":"publisher","first-page":"1365","DOI":"10.1086\/592281","volume":"198","author":"ND Walter","year":"2008","unstructured":"Walter ND, Grant GB, Bandy U, Alexander NE, Winchell JM, Jordan HT, Sejvar JJ, et al. Community outbreak of Mycoplasma pneumoniae infection: school-based cluster of neurologic disease associated with household transmission of respiratory illness. J Infect Dis. 2008;198(9):1365\u201374. \n                    https:\/\/doi.org\/10.1086\/592281\n                    \n                  .","journal-title":"J Infect Dis"},{"key":"4473_CR24","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1128\/AAC.00779-07","volume":"52","author":"M Morozumi","year":"2008","unstructured":"Morozumi M, Iwata S, Hasegawa K, Chiba N, Takayanagi R, Matsubara K, et al. Acute Respiratory Diseases Study Group. Increased macrolide resistance of Mycoplasma pneumoniae in pediatric patients with community-acquired pneumonia. Antimicrob Agents Chemother. 2008;52:348\u201350. \n                    https:\/\/doi.org\/10.1128\/AAC.00779-07\n                    \n                  .","journal-title":"Antimicrob Agents Chemother"},{"issue":"6","key":"4473_CR25","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1007\/s10156-009-0715-7","volume":"15","author":"K Matsubara","year":"2009","unstructured":"Matsubara K, Morozumi M, Okada T, Matsushima T, Komiyama O, Shoji M, et al. A comparative clinical study of macrolide-sensitive and macrolide-resistant Mycoplasma pneumoniae infections in pediatric patients. J Infect Chemother. 2009;15(6):380\u20133.","journal-title":"J Infect Chemother"},{"issue":"2","key":"4473_CR26","doi-asserted-by":"publisher","first-page":"1034","DOI":"10.1128\/AAC.01806-13","volume":"58","author":"Y Zhou","year":"2014","unstructured":"Zhou Y, Zhang Y, Sheng Y, Zhang L, Shen Z, Chen Z. More complications occur in macrolide-resistant than in macrolide-sensitive Mycoplasma pneumoniae pneumonia. Antimicrob Agents Chemother. 2014;58(2):1034\u20138. \n                    https:\/\/doi.org\/10.1128\/AAC.01806-13\n                    \n                  .","journal-title":"Antimicrob Agents Chemother"}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-019-4473-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12879-019-4473-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-019-4473-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,10,20]],"date-time":"2020-10-20T23:11:56Z","timestamp":1603235516000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcinfectdis.biomedcentral.com\/articles\/10.1186\/s12879-019-4473-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,10,22]]},"references-count":26,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["4473"],"URL":"https:\/\/doi.org\/10.1186\/s12879-019-4473-6","relation":{},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,10,22]]},"assertion":[{"value":"17 November 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 September 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 October 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Approval for the study was obtained from the ethics committee of Beijing Shunyi Center for Disease Control and Prevention (Shunyi CDC). The verbal consent was obtained from one guardian (either father or mother) of each patient before enrollment. In an outbreak investigation situation, the ethics committee approved this procedure to conduct an investigation after obtaining verbal consent.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"871"}}